96 studies found for:    Open Studies | "Peritoneal Dialysis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis;   Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA);   Drug: recombinant deoxyribonuclease (DNase)
2 Recruiting Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites
Conditions: Peritoneal Dialysis;   Continuous Ambulatory Peritoneal Dialysis;   End Stage Renal Failure;   Chronic Renal Failure
Interventions: Drug: Haelan tape (steroid impregnated tape);   Drug: Silver Nitrate
3 Not yet recruiting Improving Outcomes in Peritoneal Dialysis
Conditions: Chronic Kidney Disease;   Peritoneal Dialysis Access
Intervention:
4 Unknown  Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
Conditions: End Stage Renal Disease;   Peritoneal Dialysis
Intervention:
5 Recruiting The Effects Nutrition Status and Body Composition On Peritoneal Dialysis Outcome
Conditions: Peritoneal Dialysis;   Wasting and Malnutrition
Intervention:
6 Unknown  Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients
Conditions: Fluid Status;   Peritoneal Dialysis
Intervention:
7 Unknown  Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)
8 Unknown  Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Conditions: End-Stage Kidney Disease;   Peritoneal Dialysis
Intervention: Drug: N-acetylcysteine
9 Unknown  Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
Conditions: ESRD;   Peritoneal Dialysis
Intervention: Drug: Oral N-Acetylcysteine 1200 mg x 2/day for 4 weeks.
10 Unknown  Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
Conditions: Renal Failure, End Stage;   Peritoneal Dialysis
Intervention: Drug: Simvastatin
11 Recruiting Effect of Bio-impedance Analysis and Vitamin D vs Usual Care on Left Ventricular Mass in Peritoneal Dialysis Patients: A Randomized Controlled Trial (FLUID Study)
Condition: Peritoneal Dialysis
Interventions: Drug: Bioimpedance and Vitamin D;   Drug: Usual care and placebo;   Drug: Usual care and Vitamin D;   Device: Bioimpedance and Placebo
12 Not yet recruiting Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
Conditions: Functionally Anuric;   Hemodialysis/Peritoneal Dialysis
Intervention: Other: Adjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis
13 Recruiting The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients
Conditions: Disorders Associated With Peritoneal Dialysis;   Hyperuricemia
Intervention:
14 Not yet recruiting Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.
Conditions: Chronic Kidney Disease;   Peritoneal Dialysis
Intervention:
15 Not yet recruiting Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients
Conditions: Chronic Kidney Disease;   Peritoneal Dialysis
Interventions: Procedure: treatment arm;   Behavioral: Control arm
16 Recruiting Diurnal Variation of Mineral Metabolism and Protein Fermentation Metabolites in Peritoneal Dialysis Patients and Healthy Volunteers
Condition: Peritoneal Dialysis
Intervention:
17 Recruiting Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS
Condition: Peritoneal Dialysis, Continuous Ambulatory
Interventions: Device: BCM-guided fluid management;   Procedure: Fluid management based on the clinical information alone
18 Unknown  The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
Condition: Continuous Ambulatory Peritoneal Dialysis
Interventions: Drug: Enalapril;   Drug: Enalapril plus Losartan;   Drug: Placebo
19 Recruiting Natural History of Mineral Metabolism Parameters and Protein-bound Toxins in Incident Peritoneal Dialysis Patients
Condition: Complication of Peritoneal Dialysis
Intervention:
20 Recruiting A Study of Domestic Automated Peritoneal Dialysis Machine
Condition: Disorders Associated With Peritoneal Dialysis
Interventions: Other: APD;   Other: CAPD

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years